Trials / Unknown
UnknownNCT04220164
Observation of Blood Lipid Outcomes in Lipid Clinic
Observation of Blood Lipid Outcomes in Patients Who Receive Treatment in Lipid Clinic of Taipei MacKay Memorial Hospital
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Mackay Memorial Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
Taipei MacKay Memorial Hospital will establish a Lipid Clinic for hyperlipidemic patients. In this Lipid Clinic, the physician will discuss with each individual patient and set an individualized LDL goal according to current guideline and regulation of National Health Insurance Administration (NHIA). The aim of this study is to observe blood lipid outcomes in patients who receive treatment in Lipid Clinic of Taipei MacKay Memorial Hospital.
Detailed description
Hyperlipidemia is a major risk factor of atherosclerotic cardiovascular disease (ASCVD), and therefore it is beneficial to prevent the risk of ASCVD by controlling the prevalence of hyperlipidemia. According to CEPHEUS Pan-Asia survey, the rate of LDL goal attainment in hyperlipidemic patients of Taiwan was suboptimal, especially in high-risk patients. 2017 Taiwan lipid guideline for high-risk patients has been published and clearly defined the treatment goal of blood LDL-C for high-risk patients. Besides, Taipei MacKay Memorial Hospital will establish a Lipid Clinic for hyperlipidemic patients. In this Lipid Clinic, the physician will discuss with each individual patient and set an individualized LDL goal according to current guideline and regulation of National Health Insurance Administration (NHIA). The aim of this study is to observe blood lipid outcomes in patients who receive treatment in Lipid Clinic of Taipei MacKay Memorial Hospital.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Education and inform the optimal threshold of LDL-C levels | Physicians educate patients and provide a clear information about optimal LDL-C value according to individual patient's condition according to current guidelines |
Timeline
- Start date
- 2020-01-03
- Primary completion
- 2020-12-31
- Completion
- 2025-12-31
- First posted
- 2020-01-07
- Last updated
- 2020-01-07
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04220164. Inclusion in this directory is not an endorsement.